# Use of Translational Science, Continuous Glucose Monitoring in the Primary Care Setting for Management of Nesidioblastosis: A Case Report and Literature Review

**Authors:** Karuna Manandhar, Othman Farahneh, Ahmad Damlakhy, Ali Lattouf, Gerardo Munoz Monaco

PMC · DOI: 10.7759/cureus.59388 · Cureus · 2024-04-30

## TL;DR

A 60-year-old woman with a history of gastric bypass surgery experienced hypoglycemia due to nesidioblastosis, a rare condition linked to such surgeries.

## Contribution

This case report adds to the understanding of adult-onset nesidioblastosis following Roux-en-Y gastric bypass surgery.

## Key findings

- Nesidioblastosis was diagnosed in a 60-year-old female with a history of Roux-en-Y gastric bypass.
- Hypoglycemia episodes were observed, and insulinoma was ruled out as the cause.
- The case highlights the growing association between gastric bypass surgery and nesidioblastosis in adults.

## Abstract

Nesidioblastosis is a term used to describe histologic changes in the pancreatic cell, which are defined by beta cell hypertrophy and the formation of ductoinsular complexes. It is a disease previously most extensively identified in neonates and is a rare cause of endogenous hypoglycemia in the adult population. However, with increasing numbers of gastric bypass surgeries for the management of obesity in recent years, there has been a growing number of populations with post-gastric bypass surgery-related nesidioblastosis. Here, we will present a case of a 60-year-old female with a history of Roux-en-Y gastric bypass (RYGB) surgery who initially presented with loss of consciousness and episodes of suspected hypoglycemia. Insulinoma was ruled out, supporting the diagnosis of adult onset RYGB-associated nesidioblastosis.This article was previously presented as a poster presentation at the 2023 Research Symposium, International Conference on Health Disparities, on September 8, 2023.

## Linked entities

- **Diseases:** Nesidioblastosis (MONDO:0017182), hypoglycemia (MONDO:0004946), insulinoma (MONDO:0024677)

## Full-text entities

- **Diseases:** obesity (MESH:D009765), hypertrophy (MESH:D006984), hypoglycemia (MESH:D007003), Nesidioblastosis (MESH:D044903), Insulinoma (MESH:D007340), Health Disparities (MESH:D011019), endogenous hypoglycemia (MESH:D003866), loss of consciousness (MESH:D014474)
- **Chemicals:** Glucose (MESH:D005947)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11139435/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11139435/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC11139435/full.md

---
Source: https://tomesphere.com/paper/PMC11139435